Renée Komorowski
Amgen (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Hormonal Regulation and Hypertension, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → Enhancement of therapeutic protein in vivo activities through glycoengineering(2003)511 cited
- → Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys(2017)227 cited
- → Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models(2018)219 cited
- → Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex(2012)211 cited
- → Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue(2015)194 cited
- → A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings(2024)167 cited
- → Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys(2012)149 cited
- → Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys(2009)133 cited
- → Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia(2009)106 cited
- → Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors(2013)97 cited